Brief: Provectus Biopharmaceuticals Announces Presentation Of Cancer Immunotherapy PV-10 Poster For HNSCC At AACR 2024 Annual Meeting
11/04/2024 15:38
April 11 (Reuters) - Provectus Biopharmaceuticals Inc
PVCT.PK :
* PROVECTUS BIOPHARMACEUTICALS ANNOUNCES PRESENTATION OF
CANCER
IMMUNOTHERAPY PV-10 POSTER FOR HNSCC AT AACR 2024 ANNUAL MEETING
Source text for Eikon: ID:nGNX52g3Vc
Further company coverage: PVCT.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Provectus Biopharmaceuticals
See all newsBrief: Provectus Biopharmaceuticals Reports Oral Pv-10 Anti-Tumor Activity In Preclinical Bladder Cancer Study
Brief: Provectus Biopharmaceuticals Initiates Preclinical Study Of Oral Pv-10
RCS - VisiRose - VisiRose Introduces Therapy for Eye Infections
RCS - FINOS - FINOS Welcomes Seven Financial Leaders
Brief: Provectus Biopharmaceuticals Announces Poster Presentation of Rose Bengal Sodium for Treatment of Full-Thickness Cutaneous Wounds at SID 2024 Annual Meeting